Clinical trial
Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With…
NCT00084539 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00084539 |
|---|---|
| Title | Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer |
| Official title | Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy (IMRT) With Incorporated Boost in Early Stage Breast Cancer |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Radiation |
| Interventions | Radiation therapy |
| Enrollment | 78 |
| Start date | Nov 1, 2003 |
| Primary completion | Nov 1, 2005 |
| First posted | Jun 11, 2004 |
| Last update posted | Mar 3, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: